{"id":368864,"date":"2025-12-05T14:00:46","date_gmt":"2025-12-05T08:30:46","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=368864"},"modified":"2025-12-05T14:58:45","modified_gmt":"2025-12-05T09:28:45","slug":"sam-advises-eris-lifesciences-acquisition-swiss-parenterals","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","title":{"rendered":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited"},"content":{"rendered":"
\n

New Delhi | December 4th, 2025:<\/span> Shardul Amarchand Mangaldas & Co. (SAM) acted as the legal advisor to Eris Lifesciences Limited (“ELL”) in connection with its proposed acquisition of 30% of the total share capital of Swiss Parenterals Limited (“SPL”) (in which ELL currently holds 70% of the share capital) from Mr. Naishadh Shah (Director, SPL), for an aggregate consideration of INR 423.30 crores. The consideration will be discharged by ELL by way of issuance of equity shares of ELL to Mr. Naishadh Shah, on a preferential basis.<\/p>\n

Upon completion of the proposed acquisition, subject to receipt of necessary stock exchange approvals, SPL will become a wholly owned subsidiary of ELL.<\/p>\n

The SAM transaction team was led by Nivedita Tiwari, Partner, and Devesh Pandey, Partner, along with Kuhuk Jain, Principal Associate; Anushka Ganguli, Associate; and Sourav Paul, Associate.<\/p>\n

Gouri Puri, Partner, Rahul Yadav, Partner and Nimish Malpani, Principal Associate advised ELL on the tax related aspects pertaining to the transaction.<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals, making it a wholly owned subsidiary.<\/p>\n","protected":false},"author":67011,"featured_media":368884,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[45282,2],"tags":[94175,94171,94169,92873,94176,94174,94172,46701,94173,94170],"class_list":["post-368864","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-firms-news","category-news","tag-corporate-transaction-india","tag-ell-spl-acquisition","tag-eris-lifesciences-acquisition","tag-ma-law-firms-india","tag-pharma-sector-acquisition","tag-preferential-allotment-india","tag-sam-legal-advisory","tag-shardul-amarchand-mangaldas","tag-share-purchase-india","tag-swiss-parenterals-deal"],"yoast_head":"\nSAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times<\/title>\n<meta name=\"description\" content=\"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\" \/>\n<meta property=\"og:description\" content=\"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-05T08:30:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-05T09:28:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"headline\":\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\",\"datePublished\":\"2025-12-05T08:30:46+00:00\",\"dateModified\":\"2025-12-05T09:28:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/\"},\"wordCount\":172,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"keywords\":[\"corporate transaction India\",\"ELL SPL acquisition\",\"Eris Lifesciences acquisition\",\"M&A law firms India\",\"pharma sector acquisition\",\"preferential allotment India\",\"SAM legal advisory\",\"Shardul Amarchand Mangaldas\",\"share purchase India\",\"Swiss Parenterals deal\"],\"articleSection\":[\"Law Firms News\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/\",\"name\":\"SAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"datePublished\":\"2025-12-05T08:30:46+00:00\",\"dateModified\":\"2025-12-05T09:28:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\"},\"description\":\"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"contentUrl\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp\",\"width\":886,\"height\":590,\"caption\":\"Eris Lifesciences Swiss Parenterals acquisition\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/2025\\\/12\\\/05\\\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/#\\\/schema\\\/person\\\/84e42bab48238baf12c7e33b3d9761fe\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\\\/\\\/www.scconline.com\\\/blog\\\/post\\\/author\\\/editor_4\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times","description":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","og_locale":"en_US","og_type":"article","og_title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","og_description":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.","og_url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2025-12-05T08:30:46+00:00","article_modified_time":"2025-12-05T09:28:45+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_title":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#article","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/"},"author":{"name":"Editor","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"headline":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited","datePublished":"2025-12-05T08:30:46+00:00","dateModified":"2025-12-05T09:28:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/"},"wordCount":172,"commentCount":0,"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","keywords":["corporate transaction India","ELL SPL acquisition","Eris Lifesciences acquisition","M&A law firms India","pharma sector acquisition","preferential allotment India","SAM legal advisory","Shardul Amarchand Mangaldas","share purchase India","Swiss Parenterals deal"],"articleSection":["Law Firms News","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","url":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/","name":"SAM Advises Eris Lifesciences on Swiss Parenterals Acquisition | SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","datePublished":"2025-12-05T08:30:46+00:00","dateModified":"2025-12-05T09:28:45+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe"},"description":"SAM advised Eris Lifesciences on acquiring the remaining 30% stake in Swiss Parenterals to make it a wholly owned subsidiary.","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","width":886,"height":590,"caption":"Eris Lifesciences Swiss Parenterals acquisition"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2025\/12\/05\/sam-advises-eris-lifesciences-acquisition-swiss-parenterals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Shardul Amarchand Mangaldas Advises Eris Lifesciences Limited on the Acquisition of Remaining Stake in Swiss Parenterals Limited"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/84e42bab48238baf12c7e33b3d9761fe","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/34e366be721c41333586de05faa13743195f5b142dcd7a015c6fabd2389521d0?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/editor_4\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/12\/Eris-Lifesciences-Swiss-Parenterals-acquisition.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368864","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=368864"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/368864\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/368884"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=368864"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=368864"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=368864"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}